LC-MS bioanalysis service by LGC – DDS

Manufacturer LGC – DDS
LGC's LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.

LC-MS bioanalysis service by LGC – DDS product image
LC-MS bioanalysis service
Request Pricing

Receive your quote directly from the manufacturer.

0 Scientists have reviewed this product

Write the First Review

No Reviews

LGC continues to create new method development techniques, such as small molecule biomarkers by LC-MS/MS and apply novel technologies to help answer your analytical challenges. LGC provide small molecule drugs and biomarker analysis for pharmacokinetic (PK) and pharmacodynamics (PD) determinations from discovery support through to regulated GLP preclinical and GCP clinical studies.

Flexible services include: 

  • Fast method development / analysis for discovery compounds
  • Method development and validation for GLP TK studies and GCP clinical trials
  • Fast turnaround for Phase I Clinical Studies
  • Biomarkers by LC-MS/MS
  • Pharmacokinetic data analysis using validated software systems (e.g. WinNonlin,)
  • Logistical support for clinical sample management including sample collection kit production and supply of sampling kits, labels, investigator manual and shipping
  • Data management using LIMS or specialist software
  • Working with you to meet the shortest possible sample analysis timelines, LGC are totally committed to providing data of the highest quality, using robust bioanalytical methods.